DATA COLLECTIVE IV GP LLC
Q3 2026 Form 13-F

PALO ALTO, CALIFORNIA
CIK 0001664974 · Institutional investment manager
$63.3M Reported Value Total
Reported value
$63.3M
Quarter over quarter
-19.4%
Holdings
4
Top-10 concentration
100.0%

Key People

Named on the latest Form 13-F filing — not necessarily an owner
Spencer Punter
Authorized Signatory

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2026 13F record

Q3 2026 13F filing summary

Q3 2026 Form 13F portfolio summary
Period of report September 30, 2026
Filed November 16, 2026
Form 13F-HR
Reported value $63.3M
Positions 4
Change in reported value -19.4%
New positions 0
Exited positions 0
Position turnover 0.0%
Top-10 concentration 100.0%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 16, 2026
4 $63.3M
Q2 2026 13F
Filed Aug 14, 2026
4 $78.6M
Q1 2026 13F
Filed May 15, 2026
4 $55.9M
Q4 2025 13F
Filed Feb 17, 2026
3 $58.5M
Q3 2025 13F
Filed Nov 14, 2025
4 $68.0M
Q2 2025 13F
Filed Aug 14, 2025
5 $129.9M
Q1 2025 13F
Filed May 15, 2025
5 $86.9M
Q4 2024 13F
Filed Feb 14, 2025
6 $226.3M
Q3 2024 13F
Filed Nov 14, 2024
6 $163.5M
Q2 2024 13F
Filed Aug 14, 2024
6 $142.7M
Q1 2024 13F
Filed May 15, 2024
5 $115.3M
Q4 2023 13F
Filed Feb 14, 2024
5 $120.9M
Q3 2023 13F
Filed Nov 14, 2023
5 $105.7M
Q2 2023 13F
Filed Aug 14, 2023
6 $135.1M
Q1 2023 13F
Filed May 15, 2023
6 $93.8M
Q4 2022 13F
Filed Feb 14, 2023
6 $95.2M
Q3 2022 13F
Filed Nov 14, 2022
5 $126.5M
Q2 2022 13F
Filed Nov 14, 2022
5 $121.1M
Q1 2022 13F
Filed Nov 14, 2022
5 $471.2M
Q4 2021 13F
Filed Feb 14, 2022
5 $740.7M

Top 4 holdings · Q3 2026

Largest Q3 2026 13F positions by reported value
# Holding Reported value % of portfolio
1 RXRX Recursion Pharmaceuticals, Inc. $24.5M 38.76%
2 EVLV Evolv Technologies Holdings, Inc. $21.3M 33.72%
3 HQ Horizon Quantum Holdings Ltd $13.6M 21.48%
4 DFTX Definium Therapeutics, Inc. (MindMed) $3.8M 6.03%

Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings